Forte Biosciences
FBRX
FBRX
34 hedge funds and large institutions have $15.5M invested in Forte Biosciences in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 30 → 34 (+4)
0.24% more ownership
Funds ownership: 1.84% → 2.08% (+0.24%)
Holders
34
Holding in Top 10
–
Calls
$26K
Puts
$1K
Top Buyers
| 1 | +$71.7K | |
| 2 | +$8.62K | |
| 3 | +$4.82K | |
| 4 |
Renaissance Technologies
New York
|
+$1.62K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.45K |
Top Sellers
| 1 | -$7.26K | |
| 2 | -$7.13K | |
| 3 | -$1.3K | |
| 4 |
Two Sigma Advisers
New York
|
-$1.23K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$349 |